Lynch Syndrome: An updated review

Genes

Volumn 5, Issue 3, 2014, Pages 497-507

  Sehgal, Rishabh ^a   Sheahan, Kieran ^a   O'Connell, Patrick R ^a   Hanly, Ann M ^a   Martin, Sean T ^a   Winter, Desmond C ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

CRC clinic; Genetics; History; Lynch syndrome; Screening

Indexed keywords

EPITHELIAL CELL ADHESION MOLECULE; MISMATCH REPAIR PROTEIN PMS2; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6;

ARTICLE; CANCER RISK; CANCER SCREENING; CANCER SUSCEPTIBILITY; COLORECTAL CANCER; ENDOMETRIUM CANCER; EPCAM GENE; EPIGENETICS; FAMILY HISTORY; GENE; GENE MUTATION; GENE SILENCING; GENETIC COUNSELING; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; IMMUNOHISTOCHEMISTRY; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; MLH1 GENE; MSH2 GENE; MSH6 GENE; PMS2 GENE; PROTEIN EXPRESSION; SCREENING TEST;

EID: 84903512642     PISSN: None     EISSN: 20734425     Source Type: Journal    
DOI: 10.3390/genes5030497     Document Type: Article

References (54)

1. Hampel, H.; Frankel, W. L.; Martin, E.; Arnold, M.; Khanduja, K.; Kuebler, P.; Clendenning, M.; Sotamaa, K.; Prior, T.; Westman, J. A.; et al. Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J. Clin. Oncol. 2008, 26, 5783-5788.
2. De Jong, A. E.; Morreau, H.; van Puijenbroek, M.; Eilers, P. H.; Wijnen, J.; Nagengast, F. M.; Griffioen, G.; Cats, A.; Menko, F. H.; Kleibeuker, J. H. The role of mismatch repair gene defects in the development of adenomas in patients with HNPCC. Gastroenterology 2004, 126, 42-48.
3. Warthin, A. S. Heredity with reference to carcinoma as shown by the study of the cases examined in the pathological laboratory of the University of Michigan, 1895-1913. Arch. Intern. Med. 1913, 12, 546-555.
4. Thorson, A. G.; Knezetic, J. A.; Lynch, H. T. A century of progress in hereditary nonpolyposis colorectal cancer (Lynch syndrome). Dis. Colon Rectum 1999, 42, 1-9.
5. Boland, C. R.; Lynch, H. T. The History of Lynch Syndrome. Fam. Cancer 2013, 12, 145-157.
6. Lynch, H. T.; Krush A. J.; Cancer family "G" revisited: 1895-1970. Cancer 1971, 27, 1505-1511.
7. Douglas, J. A.; Gruber, S. B.; Meister, K. A.; Bonner, J.; Watson, P.; Krush, A. J.; Lynch, H. T. History and molecular genetics of Lynch syndrome in family G: A century later. JAMA 2005, 294, 2195-2202.
8. Boland, C. R.; Troncale, F. J. Familial colonic cancer without antecedent polyposis. Ann. Intern. Med. 1984, 100, 700-701.
9. Lynch, H. T.; Kimberling, W.; Albano, W. A. Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II). I. Clinical description of resource. Cancer 1985, 56, 934-938.
10. Lynch, H. T.; Schuelke, G. S.; Kimberling, W. J. Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II). II. Biomarker studies. Cancer 1985, 56, 939-951.
11. Vasen, H. F.; Mecklin, J. P.; Khan, P. M.; Lynch, H. T. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis. Colon Rectum 1991, 34, 424-425.
12. Vasen, H. F.; Watson, P.; Mecklin, J. P.; Lynch, H. T. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999, 116, 1453-1456.
13. Rodriguez-Bigas, M. A.; Boland, C. R.; Hamilton, S. R.; Henson, D. E.; Jass, J. R.; Khan, P. M.; Lynch, H.; Perucho, M.; Smyrk, T.; Sobin, L.; et al. A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: Meeting highlights and Bethesda guidelines. J. Natl. Cancer Inst. 1997, 89, 1758-1762.
14. Boland, C. R.; Thibodeau, S. N.; Hamilton, S. R.; Sidransky, D.; Eshleman, J. R.; Burt, R. W.; Meltzer, S. J.; Rodriguez-Bigas, M. A.; Fodde, R.; Ranzani, G. N.; et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998, 58, 5248-5257.
15. Umar, A.; Boland, C. R.; Terdiman, J. P.; Syngal, S.; de la Chapelle, A.; Rüschoff, J.; Fishel, R.; Lindor, N. M.; Burgart, L. J.; Hamelin, R.; et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J. Natl. Cancer Inst. 2004, 96, 261-268.
16. Boland, C. R.; Shike, M. Report from the Jerusalem workshop on Lynch syndrome-hereditary nonpolyposis colorectal cancer. Gastroenterology 2010, 138, 2197. e1-2197. e17.
17. Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. Recommendations from the EGAPP Working Group: Genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet. Med. 2009, 11, 35-41.
18. Aaltonen, L. A.; Peltomaki, P.; Leach, F. S.; Sistonen, P.; Pylkkänen, L.; Mecklin, J. P.; Järvinen, H.; Powell, S. M.; Jen, J.; Hamilton, S. R.; et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993, 260, 812-816.
19. Thibodeau, S. N.; Bren, G.; Schaid, D. Microsatellite instability in cancer of the proximal colon. Science 1993, 260, 816-819.
20. Ionov, Y.; Peinado, M. A.; Malkhosyan, S.; Shibata, D.; Perucho, M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 1993, 363, 558-561.
21. Fishel, R.; Kolodner, R. D. Identification of mismatch repair genes and their role in the development of cancer. Curr. Opin. Genet. Dev. 1995, 5, 382-395.
22. Lynch, H. T.; Boland, C. R.; Rodriguez-Bigas, M. A.; Amos, C.; Lynch, J. F.; Lynch, P. M. Who should be sent for genetic testing in hereditary colorectal cancer syndromes? J. Clin. Oncol. 2007, 25, 3534-3542.
23. Jass, J. R. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 2007, 50, 113-130.
24. Laurent-Puig, P.; Cayre, A.; Manceau, G.; Buc, E.; Bachet, J. B.; Lecomte, T.; Rougier, P.; Lievre, A.; Landi, B.; Boige, V. Analysis of PTEN, BRAF, and EGFRstatus in determining benefit from cetuximab therapy in wild-type KRAS metastatic colon cancer. J. Clin. Oncol. 2009, 27, 5924-5930.
25. Barnetson, R. A.; Tenesa, A.; Farrington, S. M.; Nicholl, I. D.; Cetnarskyj, R.; Porteous, M. E.; Campbell, H.; Dunlop, M. G. Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. N. Engl. J. Med. 2006, 354, 2751-2763.
26. Hampel, H.; Frankel, W. L.; Martin, E.; Arnold, M.; Khanduja, K.; Kuebler, P.; Nakagawa, H.; Sotamaa, K.; Prior, T. W.; Westman, J.; et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N. Engl. J. Med. 2005, 352, 1851-1860.
27. Vasen, H. F.; Stormorken, A.; Menko, F. H.; Nagengast, F. M.; Kleibeuker, J. H.; Griffioen, G.; Taal, B. G.; Moller, P.; Wijnen, J. T. MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: A study of hereditary nonpolyposis colorectal cancer families. J. Clin. Oncol. 2001, 19, 4074-4080.
28. Lin, K. M.; Shashidharan, M.; Ternent, C. A.; Thorson, A. G.; Blatchford, G. J.; Christensen, M. A.; Lanspa, S. J.; Lemon, S. J.; Watson, P.; Lynch, H. T.; et al. Colorectal and extracolonic cancer variations in MLH1/MSH2 hereditary nonpolyposis colorectal cancer kindreds and the general population. Dis. Colon Rectum 1998, 41, 428-433.
29. Hendriks, Y. M.; Wagner. A.; Morreau. H.; Menko, F.; Stormorken, A.; Quehenberger, F.; Sandkuijl, L.; Møller, P.; Genuardi, M.; van Houwelingen, H. Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: Impact on counseling and surveillance. Gastroenterology 2004, 127, 17-25.
30. Buchanan, D. D.; Tan, Y. Y.; Walsh, M. D.; Clendenning, M.; Metcalf, A. M.; Ferguson, K.; Arnold, S. T.; Thompson, B. A.; Lose, F. A.; Parsons, M. T.; et al. Tumor Mismatch Repair Immunohistochemistry and DNA MLH1 Methylation Testing of Patients With Endometrial Cancer Diagnosed at Age Younger Than 60 Years Optimizes Triage for Population-Level Germline Mismatch Repair Gene Mutation Testing. J. Clin. Oncol. 2014, 32, 90-100.
31. Senter, L.; Clendenning, M.; Sotamaa, K.; Hampel, H.; Green, J.; Potter, J. D.; Lindblom, A.; Lagerstedt, K.; Thibodeau, S. N.; Lindor, N. M.; et al. The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. Gastroenterology 2008, 135, 419-428.
32. Ligtenberg, M. J.; Kuiper, R. P.; Chan, T. L.; Goossens, M.; Hebeda, K. M.; Voorendt, M.; Lee, T. Y.; Bodmer, D.; Hoenselaar, E.; Hendriks-Cornelissen, S. J.; et al. Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1. Nat. Genet. 2009, 41, 112-117.
33. Kempers, M. J.; Kuiper, R. P.; Ockeloen, C. W.; Chappuis, P. O.; Hutter, P.; Rahner, N.; Schackert, H. K.; Steinke, V.; Holinski-Feder, E.; Morak, M.; et al. Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: A cohort study. Lancet Oncol. 2011, 12, 49-55.
34. Vasen, H. F.; Blanco, I.; Aktan-Collan, K.; Gopie, J. P.; Alonso, A.; Aretz, S.; Bernstein, I.; Bertario, L.; Burn, J.; Capella, G.; et al. Revised guidelines for the clinical management of Lynch syndrome (HNPCC): Recommendations by a group of European experts. Gut 2013, 62, 812-823.
35. Wijnen, J. T.; Brohet, R. M.; van Eijk, R.; Jagmohan-Changur, S.; Middeldorp, A.; Tops, C. M.; van Puijenbroek, M.; Ausems, M. G.; Gómez García, E.; Hes, F. J.; et al. Chromosome 8q23. 3 and 11q23. 1 variants modify colorectal cancer risk in Lynch syndrome. Gastroenterology 2009, 136, 131-137.
36. Lindor, N. M.; Rabe, K.; Petersen, G. M.; Haile, R.; Casey, G.; Baron, J.; Gallinger, S.; Bapat, B.; Aronson, M.; Hopper, J.; et al. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: Familial colorectal cancer type X. JAMA 2005, 293, 1979-1985.
37. InSiGHT: Colon Cancer Gene Variant Databases. Available online: http://chromium. liacs. nl/LOVD2/colon_cancer/home. php/(accessed on 5 February 2014).
38. Kohonen-Corish, M. R.; Macrae, F.; Genuardi, M.; Aretz, S.; Bapat, B.; Bernstein, I. T.; Burn, J.; Cotton, R. G.; den Dunnen, J. T.; Frebourg, T.; et al. Deciphering the colon cancer genes-Report of the InSiGHT-Human Variome Project Workshop, UNESCO, Paris, 2010. Hum. Mutat. 2011, 32, 491-494.
39. Thompson, B. A.; Spurdle, A. B.; Plazzer, J. P.; Greenblatt, M. S.; Akagi, K.; Al-Mulla, F.; Bapat, B.; Bernstein, I.; Capellá, G.; den Dunnen, J. T.; et al. Application of a 5 tiered scheme for standardized classification of 2360 unique mismatch repair gene variants in the InSiGHT locus specific database. Nat. Genet. 2014, 46, 107-115.
40. Smith, R. A.; von Eschenbach, A. C.; Wender, R.; Levin, B.; Byers, T.; Rothenberger, D.; Brooks, D.; Creasman, W.; Cohen, C.; Runowicz, C.; et al. American Cancer Society guidelines for the early detection of cancer: Update of early detection guidelines for prostate, colorectal, and endometrial cancers. CA Cancer J. Clin. 2001, 51, 38-75.
41. Winawer, S.; Fletcher, R.; Rex, D.; Bond, J.; Burt, R.; Ferrucci, J.; Ganiats, T.; Levin, T.; Woolf, S.; Johnson, D.; et al. Colorectal cancer screening and surveillance: Clinical guidelines and rationale update based on new evidence. Gastroenterology 2003, 124, 544-560.
42. Church, J.; Simmang, C.; Standards Task Force; American Society of Colon and Rectal Surgeons; Collaborative Group of the Americas on Inherited Colorectal Cancer and the Standards Committee of The American Society of Colon and Rectal Surgeons. Practice parameters for the treatment of patients with dominantly inherited colorectal cancer (familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer). Dis. Colon Rectum 2003, 46, 1001-1012.
43. National Comprehensive Cancer Network: NCCN Practice Guidelines in Oncology. Available online: http://www. nccn. org/professionals/physician_gls/default. asp/(accessed on 26 January 2014).
44. Cohen, S. A. Current Lynch Syndrome Tumor Screening Practices: A Survey of Genetic Counselors. J. Genet. Couns. 2014, 23, 38-47.
45. Patel, S. G.; Ahnen, D. J. Familial colon cancer syndromes: An update of a rapidly evolving field. Curr. Gastroenterol. Rep. 2012, 14, 428-438.
46. Polakis, P. The many ways of Wnt in cancer. Curr. Opin. Genet. Dev. 2007, 17, 45-51.
47. De la Chapelle, A.; Palomaki, G.; Hampel, H. Identifying Lynch syndrome. Int. J. Cancer 2009, 125, 1492-1493.
48. Kastrinos, F.; Balmaña, J.; Syngal, S. Prediction models in Lynch syndrome. Fam. Cancer. 2013 12, 217-228.
49. Tranø, G.; Wasmuth, H. H.; Sjursen, W.; Hofsli, E.; Vatten, L. J. Awareness of heredity in colorectal cancer patients is insufficient among clinicians: A Norwegian population-based study. Colorectal Dis. 2009, 11, 456-461.
50. Mvundura, M.; Grosse, S. D.; Hampel, H.; Palomaki, G. E. The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer. Genet. Med. 2010, 12, 93-104.
51. Aoki, K.; Taketo, M. M. Adenomatous polyposis coli (APC): A multi-functional tumor suppressor gene. J. Cell. Sci. 2007, 120, 3327-3335.
52. Hampel, H. Point: Justification for Lynch syndrome screening among all patients with newly diagnosed colorectal cancer. J. Natl. Compr. Cancer Netw. 2010, 8, 597-601.
53. Sanchez, J. A.; Vogel, J. D.; Kalady, M. F.; Bronner, M. P.; Skacel, M.; Church, J. M. Identifying Lynch syndrome: We are all responsible. Dis. Colon Rectum 2008, 51, 1750-1756.
54. Moreira, L.; Balaguer, F.; Lindor, N.; de la Chapelle, A.; Hampel, H.; Aaltonen, L. A.; Hopper, J. L.; Le Marchand, L.; Gallinger, S.; Newcomb, P. A.; et al. Identification of Lynch syndrome among patients with colorectal cancer. JAMA 2012, 308, 1555-1565.